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The Relationship Between Self-Efficacy and
Self-Reported Physical Functioning in 
Chronic Obstructive Pulmonary Disease and
Chronic Heart Failure
Rosemarie Arnold, PhD; Adelita V. Ranchor, PhD; Mike J. L. DeJongste, MD, PhD; Gerard H. Köeter,
MD, PhD; Nick H. T. Ten Hacken, MD, PhD; René Aalbers, MD, PhD; Robbert Sanderman, PhD 
In this study, the authors investigated whether self-reported physical functioning
of patients with chronic obstructive pulmonary disease (COPD) and chronic
systolic heart failure (CHF) was primarily explained by illness-specific differ-
ences related to diagnosis or whether more generic factors also contributed to
their physical functioning. Consecutive patients with COPD (n = 56; mean age
= 67.8, SD = 8.5) and CHF (n = 65; mean age = 60.0, SD = 10.2) from the out-
patient clinics of a university hospital and a general hospital completed a self-
report questionnaire, including the Rand-36 Health Survey, Cantril’s ladder, the
Mastery scale, the Perceived Health Competence Scale, and the Self-efficacy
scale. COPD patients scored significantly worse in self-reported physical and
psychological functioning and perceived health competence than did patients
with CHF. Regression analysis revealed that both the diagnosis and the illness
severity contributed to self-reported physical functioning, although self-efficacy
explained the main part of physical functioning. Therefore, important aims in
the treatment of patients with COPD and CHF should be not only improving
physical functioning but also enhancing self-efficacy.
Index Terms: chronic obstructive pulmonary disease, congestive heart fail-
ure, health status, quality of life, self-efficacy
Chronic obstructive pulmonary disease (COPD) and chron-
ic systolic heart failure (CHF) are both seriously disabling
conditions that have a profound impact on both the func-
tional status1 and the quality of life (QoL) of the patients
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dealing with them.2,3 These illnesses are readily compara-
ble with respect to clinical characteristics: Both COPD and
CHF are progressive illnesses, characterized by breathless-
ness and diminished exercise capacity.4 Furthermore, both
illnesses are related to a certain extent to unhealthy habits,
such as smoking. In this study, we compared patients with
COPD and CHF with respect to QoL, in particular physical
aspects of QoL, and studied which clinical and psycholog-
ical factors were related to the QoL of the patients.
In general, QoL is divided into physical, social, and psy-
chological domains.5 Researchers studying patients with
chronic lung and heart conditions reported that, compared
with healthy people, both patient groups showed a lower
physical, social, and psychological functioning.6,7 Although
patients with COPD and CHF probably experience compa-
rable functional limitations, there may be differences
between the diseases in the extent to which QoL domains
are affected8 because the underlying causes of the function-
al limitations are quite different for COPD and CHF. How-
ever, the factors that contribute to physical functioning in
COPD and CHF may be comparable. For instance, irre-
spective of the kind of diagnosis, the severity of the specif-
ic illness—the number of symptoms for instance—may be
an important determinant of physical functioning.
One psychological factor that may be related to the phys-
ical domain of QoL is personal control. Personal control
refers to individuals’ beliefs about their capacity to exert
control over their own lives.9 Previous research has revealed
that during the development of a chronic illness, the
patients’ perceptions of personal control are affected.10 Fur-
thermore, more personal control could be related to a better
QoL and well-being11 and improved physical functioning.12
Consequently, personal control seems to be an intermediate
factor in the relationship between a chronic illness and the
patients’ QoL.
Several forms of personal control have been described,
ranging from the more general to the more specific. Mastery
is the extent to which people feel they are in control over
their own lives in general13 and has been found to be nega-
tively associated with functional decline.14 Another form of
personal control, which refers to control over health, is per-
ceived health competence.15 Previous research has shown a
relationship between a greater perceived health competence
and added preventive health behavior, such as exercise,
abstinence from smoking, and weight maintenance.16 A
third form of personal control is self-efficacy, which con-
cerns control over specific behaviors necessary in handling
an illness. Self-efficacy has also been associated with
health-promoting behaviors, such as cessation of smok-
ing,17 adherence to medication,18 and performance of phys-
ical exercise.19 Thus, because associations were found
between several forms of personal control and functional
status and health-related behaviors, personal control is
probably also related to the QoL of patients.
Our main focus in this study was to investigate whether
self-reported physical functioning of patients with COPD
and CHF was primarily explained by illness-specific differ-
ences related to diagnosis and whether more generic factors
also contribute to physical functioning. We hypothesized
that type of diagnosis and illness severity contribute to phys-
ical functioning both directly and indirectly through person-
al control (see Figure 1). As a secondary purpose of this
study, we compared the patients with COPD and CHF with
respect to QoL domains and perceptions of personal control.
METHOD
Participants and Study Design
We recruited consecutive patients with COPD or CHF from
April 2001 to June 2002 in the outpatient clinics of a uni-
versity hospital and a general hospital. Eligible patients
received written information about the study and an
informed consent form. We included patients if they were
(1) diagnosed with COPD or CHF, (2) aged between 40 and
80 years, (3) registered with a forced expiratory volume in
1 second (FEV1) of less than 70% of the predicted value for
COPD or a left ventricular ejection fraction (LVEF) of less
than 45% for CHF, (4) free from other pulmonary or car-
diovascular disease, (5) free from other serious disease
(such as cancer), (6) free from psychiatric problems in the
past year, and (7) fluent in the Dutch language. The study
COPD AND CHF
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Type of diagnosis Illness severity Personal control Physical functioning
FIGURE 1. Model regression analysis.
had a cross-sectional design, and we collected data by
means of self-report mailed questionnaires. The Medical
Ethics Committees of both centers approved the study.
We asked 86 patients with COPD to participate in the
study, 19 of whom did not respond and 11 of whom refused.
Patients who did not participate did not differ significantly
from the respondents with respect to age and gender. We
included 56 patients in total (response rate of 65%). In the
group of patients with CHF, we invited 110 patients for par-
ticipation, 45 of whom refused. Sixty-five patients partici-
pated in the study (response rate of 59%). Patients refusing
to participate did not differ significantly from respondents
with respect to gender. A significant difference was found in
the CHF group with respect to age: patients refusing to par-
ticipate were on average 9 years older than the participants.
Table 1 shows that the patients with COPD were on aver-
age 8 years older (p < .001) than the patients with CHF.
Other demographic variables did not differ significantly
between the groups. The proportions of severely and mod-
erately severely affected patients in each group were com-
parable, χ2(119, N = 56) = .01, p = .91.
Assessments
Clinical characteristics. We collected data on lung function
parameters (FEV1 in liters, FEV1 %pred, and FVC in liters)
in the group of patients with COPD from the patients’ med-
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TABLE 1. Demographic Variables and Clinical Characteristics of Patients With





Characteristic M SD M SD p
Age (years) 67.8 8.5 60.0 10.2 .001†
Gender (% female) 32.1 29.2 NS
Education level (%)
Primary 46.4 29.2
Lower vocational 30.4 43.1
Secondary/intermediate vocational 14.3 21.5
Higher vocational/university 8.9 6.2
Marital status (% with partner) 87.3 79.7 NS
FEV1 (l) 1.5 .7
FEV1 (%pred) 49.2 16.6
FVC (l) 3.4 .9






Illness severity (%) NS




Former smokers 69.6 69.2
Non smokers (never) 7.2 12.3
Pack-years (y) 34.6 21.1 28.3 24.5 NS
Illness duration (y) 9.6 8.0 7.8 8.2 NS
Note. NS = not significant; FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity;
LVEF = left ventricular ejection fraction; NYHA = New York Heart Association.





ical records. We collected information on LVEF and New
York Heart Association (NYHA) functional class for the
patients with CHF. Furthermore, we assessed the number of
pack-years ([number of years patients smoked × number of
cigarettes per day] / 20) and illness duration.
Illness severity. To be able to compare patients with COPD
and CHF in this study with respect to the severity of their ill-
nesses, we constructed a generic index that distinguished
between severely and moderately severely affected patients,
based on the FEV1%pred for COPD patients and the LVEF
for CHF. We classified the patients with COPD according to
the GOLD criteria20 into a severe group (FEV1%pred < 50%)
and a moderately severe group (50% ≤ FEV1%pred < 70%).
We divided patients with CHF into a severe group (LVEF <
30%), and a moderately severe group (30% ≤ LVEF < 45%),
in line with previous studies.21,22
Quality of Life. We selected three subscales from the
Rand 36-item Health Survey23,24 for the assessment of QoL,
covering the 3 major domains of QoL: physical functioning
(10 items), psychological functioning (5 items), and social
functioning (2 items). Physical functioning measures the
extent to which health interferes with daily activities, such
as climbing stairs. Psychological functioning measures
mood, including feelings of depression or tension. Social
functioning assesses interference of health with normal
social activities, such as visiting friends or relatives. All
subscales vary from 0 to 100; higher scores indicate better
functioning.
We measured Overall QoL on Cantril’s ladder,25 a scale
ranging from 0 to 10, with higher scores indicating a high-
er overall QoL. Patients answered the question: “Here is a
picture of a ladder. Suppose the top of the ladder represents
the best possible life for you and the bottom represents the
worst possible life for you. Where on the ladder do you feel
you personally stand at the present time?”
Perceptions of personal control. The Pearlin and School-
er Mastery scale26 measures the extent to which people feel
they are in control over their own lives. Examples of items
are “I have little control over the things that happen to me”
or “I can do just about anything I really set my mind to do.”
This scale consists of 5 positively formulated items and 2
negatively formulated items; the latter must be reversed. All
items add up to a total score (range 7–35); higher scores
indicate higher levels of personal control perceptions.
The Perceived Health Competence Scale15 measures the
degree to which individuals feel capable of effectively man-
aging their health outcomes. This scale consists of 4 posi-
tively formulated items and 4 negatively formulated items.
All items add up to a total score (range 8–40); higher scores
indicate higher levels of competence. Examples of items are
“I handle myself well with respect to my health” and “No
matter how hard I try, my health just doesn’t turn out the
way I would like.”
We measured self-efficacy on the self-efficacy scale of
Sullivan et al.,27 which consists of items concerning behav-
iors related to health. This scale consists of the subscales
Control Symptoms and Maintain Function. The Control
Symptoms subscale was measured by 6 items (range 0–24),
such as “How confident are you that you can control your
breathlessness by taking your medications?” The Maintain
Function subscale consists of 3 items (range 0–12), for
example, “How confident are you that you can get regular
exercise?” Items for each scale are added up to a total score;
higher scores indicate higher levels of self-efficacy.
Sociodemographic variables. We assessed age, gender,
marital status, and educational level. We assessed educa-
tional level according to the International Standard Classi-
fication of Education,28,29 which has four categories from
lower to higher educated.
Data Analysis
First, we performed t tests and χ2 tests to compare both
patient groups with respect to demographic and clinical
characteristics. Second, we tested the differences between
the groups with respect to QoL and personal control by
means of analysis of variance (ANOVA) to control for age
differences between the groups. Third, we performed bi-
variate correlation analyses to study the associations of ill-
ness severity, QoL, and personal control. In addition, we
performed a multiple regression analysis of physical func-
tioning on type of diagnosis, illness severity, and personal
control. Because the study focused on the question of
whether differences in physical functioning could be
explained mainly by illness-specific or generic factors, we
combined the groups in the regression analysis. We entered
the diagnosis and age variables in the first step of the regres-
sion analysis. We entered the illness severity variable in the
next step, and in the final step, we entered personal control
variables into the analysis.
RESULTS
Differences Between Patients With COPD and CHF in
QoL and Personal Control
Table 2 shows the unadjusted mean scores for QoL and per-
sonal control in both patient groups. After adjustment for
age differences between groups, results showed that the
COPD patients scored significantly lower than the CHF
patients in self-reported physical functioning and psycho-
logical functioning. We found no significant differences
COPD AND CHF
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between groups with respect to social functioning and over-
all QoL. With relation to perceptions of personal control, the
groups only differed significantly in perceived health com-
petence: Patients with COPD reported lower perceived
health competence than the patients with CHF. 
Relationships Between Illness Severity, Personal
Control, and Self-Reported Physical Functioning
Table 3 shows Pearson’s correlation coefficients for the rela-
tionships between self-reported physical functioning and
illness severity and personal control variables. In both
COPD and CHF patients, self-reported physical functioning
was significantly related to mastery and self-efficacy main-
tain function, whereas physical functioning was not signifi-
cantly related to self-efficacy control symptoms. For the
CHF patients, self-reported physical functioning was also
significantly related to perceived health competence (r =
.50, p < .001). 
Furthermore, in neither of the groups was illness severity
significantly related to physical functioning. Illness severity
was not significantly related to most of the variables of per-
sonal control in COPD patients. For CHF patients, we found
significant correlations between illness severity and self-
efficacy maintain function (r = –.36, p < .05). 
Contributions of Illness Severity and Personal Control
to Physical Functioning
Table 4 shows the results of the regression analysis of self-
reported physical functioning on illness severity and per-
ceptions of personal control in the entire group of patients
with COPD and CHF. 
In the first step, we entered the diagnosis variable (COPD
vs CHF) into the analysis, which revealed a significant rela-
tionship with self-reported physical functioning. Second,
age was entered, after which the diagnosis variable still
showed a significant contribution to the explanation of
physical functioning. This indicates that the difference
between the groups in self-reported physical functioning
cannot be explained entirely by age alone, but that diagno-
sis-related factors remain contributing factors in the expla-
nation of physical functioning after adjustment for age.
Third, we entered illness severity, which also contributed
significantly to self-reported physical functioning. After ill-
ness severity was entered, the contribution of diagnosis to
physical functioning remained significant. In the last step of
the regression analysis, we entered mastery, perceived
health competence, and self-efficacy subscales control
symptoms and maintain function into the analysis. Once we
entered all personal control variables, only self-efficacy
maintain function contributed significantly to the explana-
tion of self-reported physical functioning.
COMMENT
In this study, we demonstrated that both disease-specific
factors related to differences in diagnosis, and generic fac-
tors, in particular illness severity and self-efficacy, were
related to self-reported physical functioning. However,
diagnosis and illness severity did not explain additional
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TABLE 2. Differences in Quality of Life (QoL, Rand-36) and Perceptions of Personal Control Between Patients With
Chronic Obstructive Pulmonary Disease (COPD) and Patients With Chronic Heart Failure (CHF)
COPD CHF
Variable M † SD M SD 95% CI p‡
QoL
Physical functioning 40.5 26.7 54.8 27.1 –14.3 –24.0, –4.6 .03§
Social functioning 66.7 28.7 71.2 26.0 –4.4 –14.3, 5.4 NS
Psychological functioning 70.1 20.8 76.1 16.4 –6.0 –12.8, .9 .04||
Overall QoL 6.0 1.5 6.1 1.9 –.1 –.8, .5 NS
Personal control
Mastery 22.3 4.3 23.7 3.7 –1.4 –2.8, .1 NS
Perceived health competence 24.6 3.9 27.7 4.1 –3.2 –4.6, –1.7 .001¶
Self-efficacy control symptoms 19.1 2.9 19.4 2.8 –.3 –1.4, .8 NS
Self-efficacy maintain function 7.0 2.0 8.0 2.6 –1.0 –1.8, –.1 NS
Note. NS = not significant; 95% CI = 95% confidence interval.
†Unadjusted means (uncorrected for age differences between groups). ‡Adjusted p values. Analysis of variance between groups: §F(1, 118) = 4.6.
||F(1, 118) = 4.3. ¶F(1, 118) = 12.8.
Mean
difference
variance of self-reported physical functioning after we
entered the personal control variables into the analysis.
Apparently, although patients with COPD and CHF differed
with respect to their level of self-reported physical func-
tioning, the factors that contributed to physical functioning
were comparable in both groups.
In the first steps of the regression analysis, both diagno-
sis and illness severity were related to self-reported physi-
cal functioning. Differences in diagnosis may be interpret-
ed as the specific limitations and symptoms caused by each
of the illnesses, such as coughing and the production of spu-
tum for patients with COPD, and fatigue and edema for
patients with CHF. Patients with COPD reported worse
physical functioning than CHF patients. Furthermore,
patients in the severe group manifested worse physical
functioning than patients who were moderately ill. 
After the personal control variables had been entered into
the equation, only self-efficacy maintain function con-
tributed significantly to the explanation of self-reported
physical functioning. Our model hypothesized independent
effects of diagnosis and illness severity on physical func-
tioning as well as an effect through perceptions of personal
control. The results of this study partly support the model
we hypothesized, because diagnosis and illness severity
were initially related to self-reported physical functioning,
but no longer contributed after we entered self-efficacy. The
relationship of diagnosis and illness severity with physical
functioning was probably mediated by perceptions of self-
efficacy, as suggested by earlier research.30
Patients with more self-efficacy maintain function report-
ed better physical functioning. Self-efficacy maintain func-
tion indicates the confidence people have to be able to per-
form physical exercise. Because both self-efficacy Maintain
Function and the Physical subscale of the Rand-36 measure
the perceptions of patients regarding their physical func-
tioning, this association seems rather straightforward. Nev-
ertheless, the Rand-36 assesses daily activities in a rather
objective way by specifically describing the activities and
asking for the extent to which patients experience limita-
tions in these activities. Moreover, researchers have also
found relationships between self-efficacy and more objec-
tive physical performance in previous studies,19,31 which
COPD AND CHF
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TABLE 3. Pearson’s Correlation Coefficients of Illness Severity, Physical Functioning (Rand-36) and Perceptions of 
Personal Control for Patients With COPD and Patients With CHF 
Perceived
Physical health Self-efficacy Self-efficacy
Variable functioning Mastery competence control symptoms maintain function
Illness severity
COPD –.14 .09 –.09 .03 –.12
CHF –.16 –.13 –.07 .00 –.36*
Entire group –.14 –.01 –.07 .02 –.24*
Physical functioning
COPD .32* .23 .14 .60***
CHF .28* .50*** .18 .48**
Entire group .32** .39*** .17 .53***
Mastery
COPD .40** .23 .38**
CHF .41** .12 .35*









Note. *p < .05. **p < .01. ***p < .001.
supports the notion that self-efficacy is indeed related to
physical functioning. Perceived health competence and
mastery did not contribute significantly to the explanation
of self-reported physical functioning. These findings indi-
cate that the relationship between personal control and
physical functioning holds true for specific perceptions of
control concerning health behaviors, but not for more gen-
eral perceptions of personal control over life as a whole. 
Another important finding of this study are the differ-
ences between the groups for the physical and psychologi-
cal domains of QoL. CHF patients reported significantly
better results for physical and psychological functioning
than the COPD patients, after correction for age-differences
between the groups. The COPD patients in this study were
more impaired with respect to daily activities, such as walk-
ing or climbing stairs, and reported more psychological
problems, such as a depressed mood. Although we found
differences between the groups in the extent to which QoL
domains were affected, both COPD and CHF patients
scored much lower than healthy people of the same age with
respect to physical functioning and social functioning.24
These results are consistent with the low FEV1 and LVEF
means of the COPD and CHF patients in this study, which
indicates that these patient groups are quite disabled.
In this study, we created a measure of illness severity on
the basis of the FEV1%pred for COPD and the LVEF for
CHF, which was not significantly related to the physical
domain of QoL of the patients. This finding is consistent
with earlier studies,32,33 which showed that objective mea-
sures of pulmonary function and ejection fraction were not
correlated with QoL. Variables other than the objective phys-
ical measures (eg, exercise tolerance) and psychological fac-
tors (eg, anxiety or depression) are probably important cor-
relates of the physical domain of QoL of the patients.
This study has some limitations. First, as the study has a
cross-sectional design, the causal relationships between the
variables in the study cannot be ascertained and, moreover,
in this study we do not provide insight into the longitudi-
nal relationships between illness severity, personal control,
and physical functioning. Consequently, it cannot be deter-
mined whether self-efficacy affects self-reported physical
functioning or whether one’s actual physical performance
affects self-efficacy. Second, the CHF patients who refused
to participate in this study were somewhat older on average
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TABLE 4. Regression Analysis of Physical Functioning (Rand-36) on Illness Severity
and Perceptions of Personal Control for the Entire Group of Patients With Chronic
Obstructive Pulmonary Disease (COPD, n = 56) and Chronic Heart Failure (CHF,
n = 65)
Physical functioning
Predictor B SE B β
Step 1†
Diagnosis (COPD vs CHF) 14.31 4.91 .26**
Step 2‡
Diagnosis (COPD vs CHF) 11.37 5.30 .21*
Age –.38 .26 –.14
Step 3§
Diagnosis (COPD vs CHF) 12.17 5.30 .22*
Age –.28 .26 –.10
Illness severity –9.80 4.91 –.18*
Step 4||
Diagnosis (COPD vs CHF) 4.00 5.27 .07
Age –.05 .27 –.02
Illness severity –1.68 5.06 –.03
Mastery .68 .66 .10
Perceived health competence .80 .70 .12
Self-efficacy control function –.05 .88 –.01
Self-efficacy maintain function 4.84 1.25 .42***
†R 2 = .07. ‡R 2 = .08. §R 2 = .11. ||R 2 = .32.
*p < .05. **p < .01. ***p < .001.
than the patients who did participate, which may have led
to selection bias. The COPD patients in this study were on
average 8 years older than the CHF patients. Therefore, all
results in this study have been corrected for age differences
between the groups. Third, in this study, we assessed phys-
ical functioning by means of a self-report measure.
Researchers have previously uncovered discrepancies
between self-reported physical functioning and more
objective, performance-based measures of physical func-
tioning.34 Unfortunately, in this study, no data were avail-
able to compare self-reported and objectively measured
physical functioning. Fourth, the cut-off points for the ill-
ness severity variable we chose for COPD (FEV1%pred <
50%) and for CHF (LVEF < 30%) are rather arbitrary,
making group comparison debatable. However, instead of
using the median scores as cut-off points, we chose the cut-
off scores mentioned in the literature.20–22
One implication of this study, important for medical
practice, is that physical functioning is not only related to
clinical characteristics of patients with COPD and CHF but,
more important, also related to the patients’ perceptions of
self-efficacy. However, a causal relationship between self-
efficacy and physical functioning cannot be determined on
the basis of our results, which would be an interesting focus
for future studies. In the treatment of patients with COPD
and CHF, enhancing health-promoting behaviors is impor-
tant as well as improving physical functioning, because
these are behaviors necessary in the management of both
illnesses. Higher self-efficacy has been associated with
healthier behaviors, such as smoking cessation,17 and more
physical exercise and greater training achievements.31 Con-
sequently, interventions should not only aim at improving
physical functioning but also at enhancing COPD and CHF
patients’ self-efficacy. Rehabilitation programs in particular
have been found to be an appropriate intervention to
enhance both self-efficacy and physical functioning.19,31
To conclude, although there are differences between the
groups in the extent to which physical functioning is affected,
similar factors, namely illness severity and self-efficacy, con-
tribute to the explanation of self-reported physical function-
ing. For both COPD and CHF, self-efficacy maintain function
displayed the strongest relationship with physical function-
ing. We suggest that not only improving physical functioning,
but also enhancing self-efficacy, should be important aims in
the treatment of patients with COPD and CHF. 
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